Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

BK virus infection is an opportunistic viral disease caused by the BK polyomavirus, primarily affecting immunocompromised individuals, especially kidney transplant recipients. As per Liv Hospital, up to 90% of the global adult population has been infected with BK virus. According to Expert Market Research's BK virus infection epidemiology forecast, the increasing transplant population is expected to drive disease burden. Early viral reactivation monitoring remains essential.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

BK Virus Infection – Number of Cases by Year

Read more about this report - Request a Free Sample

BK Virus Infection Epidemiology Forecast Report Coverage

Expert Market Research's “BK Virus Infection Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of BK virus infection. It projects the future incidence and prevalence rates of BK virus infection cases across various populations. The study covers age, gender, and type as major determinants of the BK virus infection population. The report highlights patterns in the prevalence of BK virus infection over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of BK virus infection in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

BK Virus Infection Understanding: Disease Overview

BK virus infection is caused by the BK polyomavirus, a double-stranded DNA virus belonging to the Polyomaviridae family. Primary infection usually occurs during childhood and remains asymptomatic, after which the virus establishes lifelong latency in the kidneys and urinary tract. In immunocompromised individuals, particularly kidney and hematopoietic stem cell transplant recipients, the virus may reactivate, leading to nephropathy, hemorrhagic cystitis, or impaired graft function. The disease is generally classified based on clinical manifestations, including BK virus-associated nephropathy and hemorrhagic cystitis. Regular viral load monitoring is essential for early detection and disease management.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Region

India

High-Risk Population

Kidney transplant recipients, hematopoietic stem cell transplant recipients, and other immunocompromised individuals.

Key Diagnostic Method

Quantitative polymerase chain reaction testing for BK viral DNA.

Major Risk Factor

Long-term immunosuppressive therapy following organ transplantation.

Major gap in the market

Lack of approved targeted antiviral therapies and standardized treatment protocols.

BK Virus Infection Epidemiology Perspective

The BK virus infection epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the BK virus infection epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for BK virus infection and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

BK virus infection demonstrates a high global prevalence, with up to 90% of adults infected worldwide. Adult seroprevalence generally ranges between 80% and 90%, reflecting widespread exposure during early life and lifelong latent infection, according to Liv Hospital, Creative Diagnostics; and Rut Mora-Buch et al. (2025).

Gender-Specific Cases of the Disease

Among kidney transplant recipients diagnosed with BK virus-associated nephropathy (BKVN), 48.5% were male, indicating a relatively balanced gender distribution within the evaluated cohort. Current evidence does not demonstrate a substantial difference in overall BK virus prevalence between males and females, according to Andrea García-Lopez et al. (2024).

Age-Specific Cases of the Disease

Primary BK virus infection typically occurs during early childhood, particularly in children four years of age or younger, while seroprevalence exceeds 90% in adulthood. In one transplant cohort, the median age at BKVN diagnosis was 50 years, as per Creative Diagnostics, Andrea García-Lopez et al. (2024) and Rut Mora-Buch et al. (2025).

Ethnicity-Wise Cases of the Disease

BK virus is distributed globally without evident seasonal or socioeconomic variation. Molecular epidemiological studies demonstrate geographic differences in circulating viral strains, with BKPyV serotype I representing 71.2% of analyzed sequences worldwide, according to Janani Durairaj et al. (2024) and Zohreh Alipour et al. (2023).

Mortality and Survival Analysis of the Disease

BK virus-associated nephropathy is associated with unfavorable transplant outcomes. One long-term study reported a 1.6% incidence, a 75.7% graft loss rate, and graft survival probabilities of 38.3% at six months and 22.3% at twelve months following diagnosis, according to Andrea García-Lopez et al. (2024).

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Asymptomatic (Latent) BK Virus Infection

The majority of BK virus infections remain asymptomatic and latent throughout life. Global adult seroprevalence ranges from 80% to 90%, with infection rates exceeding 90% in adults, according to Liv Hospital; as reported by Creative Diagnostics and Rut Mora-Buch et al. (2025).

BK Virus Viremia

BK virus viremia primarily occurs in immunocompromised individuals, particularly kidney transplant recipients, and serves as an important indicator of viral reactivation requiring clinical monitoring.

BK Virus-Associated Nephropathy (BKVN)

BK virus-associated nephropathy occurs in approximately 1–10% of kidney transplant recipients. One long-term study reported an incidence of 1.6%, according to Julien Gras et al. (2023) and Andrea García-Lopez et al. (2024).

BK Virus-Associated Hemorrhagic Cystitis

BK virus-associated hemorrhagic cystitis is predominantly observed in hematopoietic stem cell transplant recipients and represents a recognized manifestation of BK virus reactivation in immunocompromised patients.

BK Virus Infection – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise BK Virus Infection Epidemiology

The BK virus infection epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

BK virus infection represents an important concern among kidney transplant recipients. Global evidence indicates adult seroprevalence exceeding 80–90%, and molecular epidemiology has identified BKPyV serotype III among sequences originating from the United States, according to Janani Durairaj et al. (2024), Liv Hospital, and Rut Mora-Buch et al. (2025).

Germany

BK virus epidemiology in Germany is primarily characterized by surveillance among kidney transplant recipients, with continued monitoring aimed at the early identification of viral reactivation and the prevention of transplant-related graft complications.

France

Epidemiological investigations in France mainly focus on BK virus infection in kidney transplant recipients, supporting routine surveillance strategies to reduce the risk of BK virus-associated nephropathy and preserve graft function.

Italy

BK virus monitoring remains an integral component of post-transplant care in Italy, with epidemiological assessments primarily directed toward identifying viral reactivation and optimizing long-term graft outcomes.

Spain

Spain has contributed to the molecular epidemiology of BK virus, with BKPyV serotype III identified among reported sequence datasets, according to Janani Durairaj et al. (2024).

United Kingdom

The increasing prevalence of chronic kidney disease among older adults has contributed to a growing kidney transplant population, reinforcing the importance of BK virus surveillance following transplantation, as per Inji Alshaer et al. (2025).

Japan

Molecular epidemiological studies have identified BKPyV serotype III in Japan, while genotype IV accounted for approximately 8% of reported BKPyV isolates, according to Janani Durairaj et al. (2024) and Zohreh Alipour et al. (2023).

India

Molecular epidemiology findings indicate a BKPyV prevalence of 82.6% within transplant-related populations, underscoring the importance of ongoing viral surveillance among kidney transplant recipients, according to Ammara Kausar et al. (2026).

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The regional BK virus infection epidemiology landscape continues to face significant challenges due to limited routine screening practices, delayed diagnosis, and the absence of approved targeted antiviral therapies. Variations in transplant surveillance protocols across the United States, Europe, Japan, and India further contribute to inconsistent disease detection and reporting. Emerging opportunities include expanding standardized BK virus screening programs for transplant recipients, improving molecular diagnostic capabilities, strengthening epidemiological registries, and advancing clinical research focused on novel antiviral agents and immune-based therapies. These developments are expected to enhance disease monitoring, improve patient outcomes, and support evidence-based healthcare planning.

BK Virus Infection: Treatment Overview

There is currently no approved antiviral therapy specifically indicated for BK virus infection. Management primarily focuses on reducing immunosuppressive therapy to restore antiviral immune responses while minimizing the risk of graft rejection. Supportive care, routine laboratory monitoring, and serial quantitative polymerase chain reaction testing are fundamental components of patient management. In selected cases, agents such as cidofovir, leflunomide, intravenous immunoglobulin, or fluoroquinolones have been investigated, although evidence supporting their efficacy remains limited. Continuous immunosuppression management and individualized clinical assessment are critical to optimizing treatment outcomes and preserving transplant function.

Key Questions Answered

  • What is the current and projected burden of BK virus infection across the 8 major markets?
  • Which countries across the 8 major markets account for the highest BK virus infection patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of BK virus infection across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of BK virus infection across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of BK virus infection across the 8 major markets?
  • How do major comorbidities and risk factors influence BK virus infection epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of BK virus infection across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the BK virus infection landscape across the 8 major markets?
  • Which therapeutic areas linked to BK virus infection are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the BK virus infection epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on BK virus infection epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for BK virus infection across the 8 major markets?

Scope of the BK Virus Infection Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of BK virus infection based on several factors.
  • BK Virus Infection Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The BK virus infection report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Diabetic Nephropathy Epidemiology Forecast

Diabetic Nephropathy Pipeline Analysis Report

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us